Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 11 Aug 2026 for KLAVIYO, INC, €47.0M.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Summit Partners Growth Equity Fund IX-A, L.P.: trading record in brief
This profile gathers the share dealings of Summit Partners Growth Equity Fund IX-A, L.P. across 2 companies, led by Klaviyo, Inc. and LifeStance Health Group, Inc. Over a trading history stretching from 10 August 2026 to 11 August 2026, the count stands at 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 11 August 2026: a transaction of €47.0M, in Klaviyo, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Summit Partners Growth Equity Fund IX-A, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
2,955,112 shares@ US$18.36Series A Common stock, par value $0.001 per shareSEC144:0001634415-26-000004
1,742,770 shares@ US$10.620.45% mcap43.6% of flowCommon StockSEC144:0001634415-26-000002
2 of 2 declarations
